Medscape3d
The Cost Effectiveness of Teriparatide as a First-line Treatment for Glucocorticoid-induced and Postmenopausal Osteoporosis Patients in Sweden
The study's objective was to determine if teriparatide is cost effective against oral bisphosphonates for two large and high risk cohorts. Methods: A computer simulation model was created to model ...
Monthly Prescribing Reference3y
Teriparatide Injection
Teriparatide (recombinant) 250mcg/mL; soln for SC inj; contains m-cresol. Teriparatide stimulates new bone formation on trabecular and cortical (periosteal and/or endosteal) bone surfaces by ...
Medscape1mon
The Cost Effectiveness of Teriparatide as a First-line Treatment for Glucocorticoid-induced and Postmenopausal Osteoporosis Patients in Sweden
The results from this study demonstrate that there are high-risk osteoporosis patient cohorts where teriparatide use as a first-line agent is a cost-effective treatment option compared to ...